Merck & Co., Inc. (MRK)

Merck Presents One-Year Results from the Pivotal Phase 2b/3 BRUNELLO Study Evaluating Remigromig, a Tri-specific Agonist of the Wingless-related Integration Site (Wnt) Pathway, in Adults with Diabetic

Merck Presents One-Year Results from the Pivotal Phase 2b/3 BRUNELLO Study Evaluating Remigromig, a Tri-specific Agonist of the Wingless-related Integration Site (Wnt) Pathway, in Adults with Diabetic Macular Edema at AAO 2026

Bristol Myers Squibb vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?

Breakfast News: The Quarter in Charts

This Stock Is Up More than 560% This Year, but It Could Drop by 38%, According to Wall Street

Novavax Soars 16%, Moderna Surges 11%, Merck Climbs 3% as Biotech Rallies

Cantor Fitzgerald Lifts Price Targets on Four Pharma Giants Amid Mixed Growth Outlooks

Merck & Co., Inc. $MRK Stake Raised by GAMMA Investing LLC

Apella Capital LLC Increases Stake in Merck & Co., Inc. $MRK

Farther Finance Advisors LLC Acquires 11,956 Shares of Merck & Co., Inc. $MRK

HALO Wins Court Order Blocking Merck's Keytruda SC in Europe

INVA vs. MRK: Which Stock Is the Better Value Option?

HP, Merck, and Seagate Just Paid Their Shareholders. Here's What Landed in Their Accounts.

3 Stocks That Have More Than Doubled the S&P 500’s Return This Year

Tempus AI Doubles Down On Moderna and Merck Cancer Vaccine Infrastructure

Merck's Keytruda Is Dealt a Legal Setback. It's Good News for This Biotech Stock.

Merck (MRK) Beats Stock Market Upswing: What Investors Need to Know

Merck Stock Down 7% in a Month: Is the Dip a Buying Opportunity?

Merck & Co., Inc. $MRK Stock Position Decreased by Park National Corp OH

Merck & Co., Inc. $MRK Shares Sold by Ferguson Wellman Capital Management Inc.